Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin plus prednisolone in severe alcoholic hepatitis
2013-003727-11Phase 4Completed
- Sponsor
- Helsinki University Hospital
- Start
- Sep 2013
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofloxacin in alcoholic hepatitis (AH) (2 arms), sponsored by Helsinki University Hospital. Primary endpoints: Mortality at day 28, Mortality at 3 months and 2 more. Started Sep 2013; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on 2013-003727-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003727-11.